These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28738306)

  • 1. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.
    Floresta G; Pistarà V; Amata E; Dichiara M; Marrazzo A; Prezzavento O; Rescifina A
    Eur J Med Chem; 2017 Sep; 138():854-873. PubMed ID: 28738306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022.
    Floresta G; Patamia V; Zagni C; Rescifina A
    Eur J Med Chem; 2022 Oct; 240():114604. PubMed ID: 35849941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation.
    Floresta G; Cilibrizzi A; Abbate V; Spampinato A; Zagni C; Rescifina A
    Bioorg Chem; 2019 Mar; 84():276-284. PubMed ID: 30529845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibitors of human adipocyte fatty acid binding protein (FABP4).
    Zhang M; Zhu W; Li Y
    Med Chem; 2014 Jun; 10(4):339-47. PubMed ID: 24024500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of BMS-309403-related compounds, including [¹⁴C]BMS-309403, a radioligand for adipocyte fatty acid binding protein.
    Okada T; Hiromura M; Otsuka M; Enomoto S; Miyachi H
    Chem Pharm Bull (Tokyo); 2012; 60(1):164-8. PubMed ID: 22223390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational Tools in the Discovery of FABP4 Ligands: A Statistical and Molecular Modeling Approach.
    Floresta G; Gentile D; Perrini G; Patamia V; Rescifina A
    Mar Drugs; 2019 Oct; 17(11):. PubMed ID: 31683588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel fatty acid binding protein 4 (FABP4) inhibitors: virtual screening, synthesis and crystal structure determination.
    Cai H; Liu Q; Gao D; Wang T; Chen T; Yan G; Chen K; Xu Y; Wang H; Li Y; Zhu W
    Eur J Med Chem; 2015 Jan; 90():241-50. PubMed ID: 25461324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.
    Lan H; Cheng CC; Kowalski TJ; Pang L; Shan L; Chuang CC; Jackson J; Rojas-Triana A; Bober L; Liu L; Voigt J; Orth P; Yang X; Shipps GW; Hedrick JA
    J Lipid Res; 2011 Apr; 52(4):646-56. PubMed ID: 21296956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
    Furuhashi M
    J Atheroscler Thromb; 2019 Mar; 26(3):216-232. PubMed ID: 30726793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
    Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new dual FABP4/5 inhibitors based on a naphthalene-1-sulfonamide FABP4 inhibitor.
    He Y; Dou H; Gao D; Wang T; Zhang M; Wang H; Li Y
    Bioorg Med Chem; 2019 Oct; 27(19):115015. PubMed ID: 31420256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From hit to lead: Structure-based discovery of naphthalene-1-sulfonamide derivatives as potent and selective inhibitors of fatty acid binding protein 4.
    Gao DD; Dou HX; Su HX; Zhang MM; Wang T; Liu QF; Cai HY; Ding HP; Yang Z; Zhu WL; Xu YC; Wang HY; Li YX
    Eur J Med Chem; 2018 Jun; 154():44-59. PubMed ID: 29775936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.
    Barf T; Lehmann F; Hammer K; Haile S; Axen E; Medina C; Uppenberg J; Svensson S; Rondahl L; Lundbäck T
    Bioorg Med Chem Lett; 2009 Mar; 19(6):1745-8. PubMed ID: 19217286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.
    Furuhashi M; Tuncman G; Görgün CZ; Makowski L; Atsumi G; Vaillancourt E; Kono K; Babaev VR; Fazio S; Linton MF; Sulsky R; Robl JA; Parker RA; Hotamisligil GS
    Nature; 2007 Jun; 447(7147):959-65. PubMed ID: 17554340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
    Boss M; Kemmerer M; Brüne B; Namgaladze D
    Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4).
    González JM; Fisher SZ
    Acta Crystallogr F Struct Biol Commun; 2015 Feb; 71(Pt 2):163-70. PubMed ID: 25664790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling lipid metabolism from inflammation through fatty acid binding protein-dependent expression of UCP2.
    Xu H; Hertzel AV; Steen KA; Wang Q; Suttles J; Bernlohr DA
    Mol Cell Biol; 2015 Mar; 35(6):1055-65. PubMed ID: 25582199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipocyte fatty acid-binding protein suppresses cardiomyocyte contraction: a new link between obesity and heart disease.
    Lamounier-Zepter V; Look C; Alvarez J; Christ T; Ravens U; Schunck WH; Ehrhart-Bornstein M; Bornstein SR; Morano I
    Circ Res; 2009 Aug; 105(4):326-34. PubMed ID: 19608978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
    Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
    J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Virtual Screening and Substructure Search for Discovery of Novel FABP4 Inhibitors.
    Cai H; Wang T; Yang Z; Xu Z; Wang G; Wang HY; Zhu W; Chen K
    J Chem Inf Model; 2017 Sep; 57(9):2329-2335. PubMed ID: 28810126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.